NHI Announces Fourth Quarter 2021 Dividend
MURFREESBORO, TN / ACCESSWIRE / November 8, 2021 / National Health Investors, Inc. (NYSE:NHI) announced today that it will pay...
News
Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading
TORONTO, ON / ACCESSWIRE / November 8, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic...
BlueCross Foundation To Award Six $10,000 Health Care Education Scholarships
BlueCross Power of We Scholarship program aims to create a more inclusive health care workforce CHATTANOOGA, Tenn.--(BUSINESS WIRE)--The BlueCross BlueShield...
RYAH Group Receives Additional Shipment Order for Major UK-based Clinical Trial
TORONTO, ON / ACCESSWIRE / November 8, 2021 / RYAH Group, Inc. (CSE:RYAH) ("RYAH" or the "Company") is pleased to...
Melzi Sharps Finder(TM) Demonstrates Improved Ability to Locate Retained Surgical Sharps (RSS)
Sharps Finder shows detection of 13mm, 17mm, and 26mm needles with a 95% reliability rateThis device addresses the standard surgical...
Jaguar Health’s Italian Subsidiary Napo EU Appoints Annabella Amatulli Chief Regulatory Officer
SAN FRANCISCO, CA / ACCESSWIRE / November 8, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced the appointment by Napo...
Aytu BioPharma to Report First Quarter Fiscal 2022 Results and Provide Business Update on November 15, 2021
ENGLEWOOD, CO / ACCESSWIRE / November 8, 2021 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing...
CDR-Life to Present at the American Society of Hematology’s 2021 Annual Meeting
ZÜRICH, Switzerland, Nov. 08, 2021 (GLOBE NEWSWIRE) -- CDR-Life Inc., a biotechnology company pioneering a new and differentiated class of...
Delcath Systems to Participate in the Canaccord Virtual MedTech, Diagnostics and Digital Health & Services Forum on November 18, 2021
NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (Nasdaq: DCTH ), an interventional oncology company focused on the treatment...
Celsion Provides Update on its Application to Sell $1.5 Million of New Jersey Net Operating Losses
Application Approval Will Further Extend Current Operating Runway to Over Three Years To date, through the New Jersey Technology Business...
Intravascular ultrasound (IVUS) linked with improved health outcomes in largest-ever real-world analysis of lower extremity peripheral vascular interventions
Philips intravascular ultrasound (IVUS) imaging - 1 Philips intravascular ultrasound (IVUS) imaging - 2 November 8, 2021 Independent analysis includes...
Prelude Therapeutics Announces IND Clearance for PRT2527, a Highly Selective CDK9 Inhibitor
Phase 1 Clinical Trial in Patients with Selected Solid Tumors Anticipated to Begin by Year-EndWILMINGTON, Del., Nov. 08, 2021 (GLOBE...
Conformis, Inc. Appoints James Paiva as its new Vice President of U.S. Marketing; Inducement Grant Reported
BILLERICA, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed James Paiva as its new...
Chiesi USA Promotes Polly Petrino to VP, Finance and Member of Leadership Team
Polly Petrino Polly Petrino, Vice President, Finance at Chiesi USA Finance leader with more than 20 years of expertise will...
Imaging Mass Cytometry Utilized to Seek Molecular Links between African Ancestry and Aggressive Forms of Breast and Prostate Cancer
IMC Studies Part of New York Genome Center’s Polyethnic-1000 Initiative Advancing Understanding of Racial Disparities in the Prevalence of Cancer...
Celsion Corporation’s GEN-1 IL-12 Program to be Featured at Cytokine-Based Cancer Immunotherapies Summit
Chief Science Officer Dr. Khursheed Anwer to also Participate in Two Panel Discussions LAWRENCEVILLE, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE)...
Longeveron to Release Third Quarter 2021 Financial Results and Hold Conference Call on November 12, 2021
MIAMI, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
Opus Genetics Announces Presence at Eyecelerator@AAO 2021
RALEIGH, N.C., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Opus Genetics, a patient-focused gene therapy company developing treatments for orphan inherited...
atai Life Sciences to Host Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Business Update
NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming...
Veru to Participate in Fireside Chat at the Jefferies London Healthcare Conference on November 16-18, 2021
MIAMI, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing...